Parathyroid carcinoma

Abstract

Parathyroid carcinoma is a rare but clinically-aggressive tumor. While most cases are sporadic, parathyroid cancer is overrepresented in hyperparathyroidism-jaw tumor syndrome, or rarely other heritable syndromes. Evidence suggests that sporadic parathyroid carcinomas rarely, if ever, evolve through an identifiable benign tumor intermediate. A few genes have been directly implicated in the pathogenesis of sporadic parathyroid cancer; somatic (and less common germline) mutations in the CDC73 tumor suppressor gene are the most frequent finding and the only firmly established molecular drivers of parathyroid cancer. Alterations in other important human cancer genes, including CCND1/cyclin D1, PIK3CA, MTOR and PRUNE2 have also been described in parathyroid cancer, however their abilities to drive malignant parathyroid tumorigenesis remains to be demonstrated experimentally.

Keywords

CDC73 / cyclin D1 / PIK3CA / hyperparathyroidism-jaw tumor syndrome

References

[1] DeLellis RA,Bilezikian JP,Larsson C,Mete O.Parathyroid Carcinoma..In: WHO Classification of Tumours of Endocrine Organs. Lyon: IARC;2017;

[2] Tahara H,Gas RD,Arnold A.Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas..Cancer Res1996;56:599-605

[3] Agarwal SK,Kester MB,Heffess CS,Marx SJ.Comparative genomic hybridization analysis of human parathyroid tumors..Cancer Genet Cytogenet1998;106:30-6

[4] Farnebo F,Teh BT,Wong FK,Elvius M,Thompson NW,Sandelin K.Alternative genetic pathways in parathyroid tumorigenesis..J Clin Endocrinol Metab1999;84:3775-80

[5] Hunt JL,Yim JH,Barnes L.Allelic loss in parathyroid neoplasia can help characterize malignancy..Am J Surg Pathol2005;29:1049-55

[6] Cromer MK,Choi M,Nelson-Williams C,Carling T.Identification of somatic mutations in parathyroid tumors using whole-exome sequencing..J Clin Endocrinol Metab2012;97:E1774-81 PMCID:PMC5393442

[7] Newey PJ,Rimmer AJ,Head RT,Gorvin CM,Gregory L,Sadler G,Buck D.Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas..J Clin Endocrinol Metab2012;97:E1995-2005 PMCID:PMC4446457

[8] Costa-Guda J,Palanisamy N,Phillip Koeffler H,Arnold A.Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins..Endocrine2013;44:489-95 PMCID:PMC3683451

[9] Kytola S,Obara T,Grimelius L,Sandelin K.Patterns of chromosomal imbalances in parathyroid carcinomas..Am J Pathol2000;157:579-86

[10] Costa-Guda J,Parekh VI,Arnold A.Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas..Horm Cancer2013;4:301-7

[11] Kasaian K,Thiessen N,Corbett RD,Nip KM,Tse K,Varhol RJ,McDonald H,Tam A,Birol I,Moore RA,Hirst M,Walker BA.Complete genomic landscape of a recurring sporadic parathyroid carcinoma..J Pathol2013;230:249-60

[12] Mehta A,Rosenberg A,Ellis RJ,Quezado MM,Simonds WF.Hyperparathyroidism-jaw tumor syndrome: results of operative management..Surgery2014;156:1315-24; discussion 1324-5 PMCID:PMC4255585

[13] Shattuck TM,Obara T,Clark OH,Wierman ME,Robbins CM,Farnebo LO,Arnold A.Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma..N Engl J Med2003;349:1722-9

[14] Howell VM,Kahnoski K,Petillo D,Fleuren GJ,Delbridge LW,Nelson AE,Hammje K,Hoang-Vu C,Marsh DJ,Teh BT.HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours..J Med Genet2003;40:657-63 PMCID:PMC1735580

[15] Cetani F,Borsari S,Dipollina G,Ambrogini E,Colussi G,Miccoli P,Marcocci C.Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors..J Clin Endocrinol Metab2004;89:5583-91

[16] Haven CJ,Tan MH,Fleuren GJ,Morreau H.Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas..Clin Endocrinol (Oxf)2007;67:370-6

[17] Cascon A,Javier Leandro-Garcia L,Suela J,Costa MB,Landa I,Rodriguez-Antona C,Robledo M.Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family..Genes Chromosomes Cancer2011;50:922-9

[18] Domingues R,Martins C,Bugalho MJ.Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism..Clin Endocrinol (Oxf)2012;76:33-8

[19] Bricaire L,Cardot-Bauters C,North MO,Vezzosi D,Murat A,Sadoul JL,Chanson P,Clauser E,Groussin L.Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism..J Clin Endocrinol Metab2013;98:E403-8

[20] Guarnieri V,Muscarella LA,Bonfitto N,Minisola S,D'Agruma L.Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance..J Clin Endocrinol Metab2006;91:2827-32

[21] Arnold A.Familial Hyperparathyroidism..In: Primer on the metabolic bone diseases and disorders of mineral metabolism.2008;361-6

[22] Tan MH,Wang P,Haven CJ,Zhao P,Korpi-Hyovalti E,Soo KC,Cao B,Morreau H.Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma..Clin Cancer Res2004;10:6629-37

[23] Gill AJ,Gimm O,Dralle H,Marsh DJ.Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias..Am J Surg Pathol2006;30:1140-9

[24] Cetani F,Viacava P,Fanelli G,Borsari S,Berti P,Pinchera A.Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?.Eur J Endocrinol2007;156:547-54

[25] DeLellis RA.Parathyroid tumors and related disorders..Mod Pathol2011;24:Suppl 2S78-93

[26] Agarwal SK,Marx SJ.The parafibromin tumor suppressor protein interacts with actin-binding proteins actinin-2 and actinin-3..Mol Cancer2008;7:65 PMCID:PMC2519076

[27] Jo JH,Youn H.Cytoplasmic parafibromin/hCdc73 targets and destabilizes p53 mRNA to control p53-mediated apoptosis..Nat Commun2014;5:5433

[28] Mosimann C,Basler K.Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo..Cell2006;125:327-41

[29] James RG,Conrad WH,Fass DM,Sommer K,Roberts BS,Arthur WT,Rawlings DJ,Moon RT.Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling..Sci Signal2009;2:ra25 PMCID:PMC4790753

[30] Takahashi A,Kikuchi I,Saito Y,Karisch R,Cho T,Rozenblatt-Rosen O,Neel BG.SHP2 tyrosine phosphatase converts parafibromin/Cdc73 from a tumor suppressor to an oncogenic driver..Mol Cell2011;43:45-56 PMCID:PMC5101830

[31] Shtutman M,Simcha I,D'Amico M,Ben-Ze'ev A.The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway..Proc Natl Acad Sci U S A1999;96:5522-7 PMCID:PMC21892

[32] Tetsu O.Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells..Nature1999;398:422-6

[33] Woodard GE,Zhang JH,Marx SJ.Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression..Oncogene2005;24:1272-6

[34] Lin L,Panicker LM.The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene..Proc Natl Acad Sci U S A2008;105:17420-5 PMCID:PMC2582266

[35] Juhlin CC,Villablanca A,Sandelin K,Larsson C.Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas..Int J Oncol2009;34:481-92

[36] Svedlund J,Sundstrom M,Akerstrom G,Westin G.Aberrant WNT/beta-catenin signaling in parathyroid carcinoma..Mol Cancer2010;9:294 PMCID:PMC2993678

[37] Iwata T,Taketani Y,Yoshimoto K.Parafibromin tumor suppressor enhances cell growth in the cells expressing SV40 large T antigen..Oncogene2007;26:6176-83

[38] Wang P,Bender S,Farber L,Ali A,Alberts AS,Shilatifard A,Teh BT.Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice..Mol Cell Biol2008;28:2930-40 PMCID:PMC2293088

[39] Walls GV,Lines KE,Reed AAC,Jeyabalan J,Bradley KJ,Chen J,Williams BO,Thakker RV.Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome..Oncogene2017;36:4025-36 PMCID:PMC5472200

[40] Zhao L,Liu DM,Tao B,Liu JM.Copy number variation in CCND1 gene is implicated in the pathogenesis of sporadic parathyroid carcinoma..World J Surg2014;38:1730-7

[41] Pandya C,Bellizzi J,Moe AS,Hamou W,Fink MY,Yu W,Cavaco BM,Thakker RV,Schadt EE,Li SD,Chen R.Genomic profiling reveals mutational landscape in parathyroid carcinomas..JCI Insight2017;2:e92061 PMCID:PMC5358487

[42] Vasef MA,Sturm M,Robinson RA.Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study..Mod Pathol1999;12:412-6

[43] Imanishi Y,Yoshimoto K,Mallya S,Kifor O,Sablosky M,Gronowicz G,Schmidt EV,Brown EM,Arnold A.Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice..J Clin Invest2001;107:1093-102 PMCID:PMC209274

[44] Cryns VL,Xu HJ,Wierman ME,Jr., Benedict WF, Arnold A. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma..N Engl J Med1994;330:757-61

[45] Cetani F,Viacava P,Fanelli G,Borsari S,Miccoli P,Pinchera A.A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer..Clin Endocrinol (Oxf)2004;60:99-106

[46] Kim JK.Nuclear cyclin D1: an oncogenic driver in human cancer..J Cell Physiol2009;220:292-6 PMCID:PMC2874239

[47] Casimiro MC,Pestell RG.Kinase independent oncogenic cyclin D1..Aging (Albany NY)2015;7:455-6 PMCID:PMC4543029

[48] Yu W,Stevenson M,Heng HL,Gan A,Huang D,Ong CK,Cavaco B,Tan P,Thakker RV.Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion..J Clin Endocrinol Metab2015;100:E360-4

[49] Sulaiman L,Hashemi J,Nordenstrom J,Juhlin CC.Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors..PLoS One2012;7:e46325 PMCID:PMC3460869

[50] Friedman E,Marx SJ,Arnold A,Aurbach GD.Genetic abnormalities in sporadic parathyroid adenomas..J Clin Endocrinol Metab1990;71:293-7

[51] Yoshimoto K,Fukuda A,Katsuragi K,Saito S.ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism..Jpn J Cancer Res1992;83:1057-62 PMCID:PMC5918679

[52] Cryns VL,Thor AD,Arnold A.p53 abnormalities in human parathyroid carcinoma..J Clin Endocrinol Metab1994;78:1320-4

[53] Hakim JP.Absence of p53 point mutations in parathyroid adenoma and carcinoma..J Clin Endocrinol Metab1994;78:103-6

[54] Shattuck TM,Costa J,Imanishi Y,Gaz RD,Clark OH,Wierman ME,Tojo K,Arnold A.Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma..Clin Endocrinol (Oxf)2003;59:180-9

[55] Dotzenrath C,Farnebo F,Svensson A,Goretzki P.Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors?.J Clin Endocrinol Metab1996;81:3194-6

[56] Pearce SH,Wooding C,Clayton RN.Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours..Clin Endocrinol (Oxf)1996;45:195-200

[57] Szijan I,Dalamon V,Danilowicz K,Cordon-Cardo C.Alterations in the retinoblastoma pathway of cell cycle control in parathyroid tumors..Oncol Rep2000;7:421-5